✦ LIBER ✦

Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors a prospective phase II study in 24 patients

✍ Scribed by Philippe Ruszniewski; Philippe Rougier; Alain Roche; Paul Legmann; Annie Sibert; Samir Hochlaf; Marc Ychou; Michel Mignon

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 533 KB
Volume: 71
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19930415)71:8<2624::aid-cncr2820710830>3.0.co;2-b

No coin nor oath required. For personal study only.

✦ Synopsis

renal failure (one patient). Abdominal pain, fever, and increases in hepatic enzyme levels were common and transient.

Conclusions. These results suggest that CE is effective in patients with liver metastases of endocrine tumors, mainly in carcinoids. In the latter, CE allows control of the carcinoid syndrome and regression or stabilization of the liver tumors in 80% of patients. Cancer 1993: 71:2624-30.

📜 SIMILAR VOLUMES

Regional biologic therapy. Hepatic arter

Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases

✍ Giora M. Mavligit; Alexander A. Zukixvski; Chuslip Charnsangavej; C. Humberto Ca 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Association between insulin-like growth

Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma : A prospective study

✍ Byung-Cheol Song; Young-Hwa Chung; Jeong A. Kim; Han Chu Lee; Hyun-Ki Yoon; Kyu- 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 3 views

Durable hepatic tumor regression after a

Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver

✍ Giora M. Mavligit; Raphael E. Pollock; Harry L. Evans; Sidney Wallace 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 694 KB

Medical treatment and long-term survival

Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors

✍ Barbro Eriksson; Britt Skogseid; Gudmar Lundqvist; Leif Wide; Erik Wilander; Kje 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 774 KB

Severe, symptomatic, dose-limiting hypop

Severe, symptomatic, dose-limiting hypophosphatemia induced by hepatic arterial infusion of recombinant tumor necrosis factor in patients with liver metastases

✍ Auro Del Giglio; Giora M. Mavligit; Alexander A. Zukiwski; Mohamed K. Ali 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 1 views

Twenty-two patients with liver metastases received 45 courses of recombinant tumor necrosis factor (rTNF] by hepatic arterial infusion in doses ranging from 12.5 to 175 pg/m2/d for 5 days by continuous infusion. The induction of statistically significant, dose-related, severe, albeit transient, hypo

A Phase II study of high-dose paclitaxel

A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors

✍ Stephen M. Ansell; Henry C. Pitot; Patrick A. Burch; Larry K. Kvols; Michelle R. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 3 views